Leah Hunter Commissioner for External Affairs (OEA) within the Office of the Commissioner at the U.S. Food and Drug Administration | Official Website
Leah Hunter Commissioner for External Affairs (OEA) within the Office of the Commissioner at the U.S. Food and Drug Administration | Official Website
This is an increase over the number of companies cited in the previous quarter.
The citations in the county include:
- Process control procedures that describe any process controls necessary to ensure conformance to specifications have not been adequately established.
- Procedures for monitoring and control of process parameters for a validated process have not been adequately established.
- Procedures have not been adequately established to control product that does not conform to specified requirements.
The company cited should take a voluntary action to correct its managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
LS Investment Group II, LLC | Devices | 10/30/2024 | Process control procedures, Lack of or inadequate procedures |
LS Investment Group II, LLC | Devices | 10/30/2024 | Lack/Inad procedure-Monitoring/Control of Validated Proces |
LS Investment Group II, LLC | Devices | 10/30/2024 | Nonconforming product, Lack of or inadequate procedures |
LS Investment Group II, LLC | Devices | 10/30/2024 | Lack of or inadequate procedures |